Delivery Order SPE2DB24D1201-SPE2DB25FJEET
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,874.60 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in a 200 mL quantity. This contract, which was competitively awarded without a set-aside designation, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. VIMPAT (lacosamide) is an antiepileptic medication used to treat partial-onset seizures, reflecting the critical pharmaceutical supply needs of federal military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,310.40 for VIMPAT 10 mg/mL Solution in a 200 mL quantity, with an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract awarded on August 19, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is an antiepileptic medication used in the treatment of seizure disorders. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,156.41 for VIMPAT 200 MG tablets (60-count) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. Performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.56 to AmerisourceBergen Drug Corp for VIMPAT 150 mg tablets (60 unit dose tablets) on October 21, 2025, with a completion date of October 22, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $1,341.90 to AmerisourceBergen Drug Corp for the supply of VIMPAT 200 mg/20 mL vials. This competitive, non-set-aside contract was executed on November 17, 2025, with an ultimate completion date of November 18, 2025, and represents a firm fixed-price transaction. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count) on October 27, 2025, with a ceiling value of $2,117.02. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency has awarded a delivery order valued at $1,221.44 to AmerisourceBergen Drug Corp for VIMPAT 150 mg tablets (60-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on October 20, 2025, and scheduled for completion by October 21, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is a controlled anticonvulsant medication used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,646.10. The contract utilizes firm fixed pricing with an ultimate completion date of December 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...